Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group
- PMID: 2865725
- DOI: 10.1016/0091-7435(85)90059-3
Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group
Abstract
Analyses of 5-year mortality data from the Hypertension Detection and Follow-up Program (HDFP) were performed with stratification according to several baseline traits. The HDFP participants were 10,940 white and black men and women ages 30-69 at baseline who were randomized to either stepped-care (SC) or referred-care (RC) groups. All-causes mortality rates were lower for the SC than the RC group, both overall and for the 90-104 mm Hg stratum, for both cigarette smokers and nonsmokers, and for persons with and without hypercholesterolemia, hyperglycemia, diagnosed diabetes, hyperuricemia, or rapid pulse rate. The SC group also fared better than RC for all strata of body mass index, with an apparent trend toward an inverse relationship between body mass index and degree of benefit. Several of the traits--cigarette smoking, fasting hyperglycemia, and hyperuricemia--were associated with significantly higher 5-year mortality rates in both SC and RC participants, in both univariate and multivariate analyses, and a significant U-shaped relationship was recorded between body mass index and mortality for both SC and RC groups. These findings indicate the broad benefit of vigorous antihypertensive stepped-care treatment for hypertensive patients regardless of the presence or absence of the other major risk factors. They also underscore the need for comprehensive management of persons with high blood pressure to control not only their hypertension but also other risk factors associated with negative impact on long-term prognosis.
Similar articles
-
Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group.JAMA. 1988 Apr 8;259(14):2113-22. JAMA. 1988. PMID: 3346988 Clinical Trial.
-
The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.Circulation. 1984 Dec;70(6):996-1003. doi: 10.1161/01.cir.70.6.996. Circulation. 1984. PMID: 6388901 Clinical Trial.
-
Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.JAMA. 1982 Feb 5;247(5):633-8. JAMA. 1982. PMID: 7033578 Clinical Trial.
-
Risk factor modification trials: implications for the elderly.Eur Heart J. 1988 Mar;9 Suppl D:9-53. doi: 10.1093/eurheartj/9.suppl_d.9. Eur Heart J. 1988. PMID: 3288476 Review.
-
Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trials.Cardiovasc Drugs Ther. 2000 Aug;14(4):357-66. doi: 10.1023/a:1007851913672. Cardiovasc Drugs Ther. 2000. PMID: 10999641 Review.
Cited by
-
Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol.Cochrane Database Syst Rev. 2001;2003(1):CD001366. doi: 10.1002/14651858.CD001366. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(3):CD001366. doi: 10.1002/14651858.CD001366. PMID: 11279715 Free PMC article. Updated.
-
Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA.J Gen Intern Med. 2018 Jul;33(7):1116-1123. doi: 10.1007/s11606-018-4471-1. Epub 2018 May 7. J Gen Intern Med. 2018. PMID: 29736755 Free PMC article.
-
Serum uric acid and left ventricular hypertrophy in hypertensive patients in Ado-Ekiti.Pan Afr Med J. 2020 Jul 16;36:190. doi: 10.11604/pamj.2020.36.190.21072. eCollection 2020. Pan Afr Med J. 2020. PMID: 32952834 Free PMC article.
-
Hyperuricemia and renal function.Curr Hypertens Rep. 2001 Jun;3(3):197-202. doi: 10.1007/s11906-001-0038-2. Curr Hypertens Rep. 2001. PMID: 11353569 Review.
-
Experiences from hypertension trials. Impact of other risk factors.Drugs. 1988;36 Suppl 3:9-20. doi: 10.2165/00003495-198800363-00005. Drugs. 1988. PMID: 3076127 Review.